Four draft revisions of pharmaceutical excipient standards are publicly announced!


The author understands that due to the late start and incomplete quality standards of China's pharmaceutical excipient industry, the market is still in the stage of gradual standardization, presenting a situation of "small, scattered, and chaotic". In recent years, the frequent occurrence of "drug harm" incidents has attracted the attention of domestic drug regulatory authorities, and the regulatory mode and management system of medicinal excipients urgently need to be improved. 
In 2006, in order to strengthen the quality management of pharmaceutical excipient production and ensure the quality of pharmaceutical excipients, China formulated the "Quality Management Standards for Pharmaceutical excipient Production". Under the fermentation of the "sulfonamide elixir incident", the defects in the registration system of medicinal excipients were exposed, which prompted China to reform the management system of medicinal excipients.

In 2008, China's drug regulatory authorities began exploring reforms in the management mode of pharmaceutical raw materials.

In 2012, China issued the "Regulations on Strengthening the Supervision and Management of Medicinal Excipients", which further clarified the regulatory mode of medicinal excipients and urged pharmaceutical manufacturers to strictly control the excipients used in drug production.

In May 2017, the "Relevant Policies on Encouraging Innovation in Drugs and Medical Devices and Accelerating the Review and Approval of New Drug Medical Devices" (draft for comments) were released, which clearly proposed the formulation of management measures for the filing of pharmaceutical raw materials and packaging materials, the establishment of an information platform for the filing of pharmaceutical raw materials and packaging materials, and relevant enterprises submitting filing materials as required and being responsible for the authenticity of the filing information, further clarifying the main responsibility of drug production enterprises for drug quality. In the past two years, China has effectively strengthened the daily supervision of pharmaceutical excipient production enterprises, strengthened the extended inspection of pharmaceutical excipients, and ensured the quality of drugs. The standard system for pharmaceutical excipients is constantly improving

Related News


L-Methionine 2026 Guide: Pharmaceutical Grade Benefits, Applications & Quality Standards

This 2026 comprehensive guide covers L-Methionine, the essential sulfur amino acid the human body cannot synthesize independently. We break down its core physiological functions, pharmaceutical grade quality benchmarks, common industrial and clinical applications, safety parameters, and key evaluation factors buyers should use when sourcing bulk L-Methionine. Backed by Jirong Pharmaceutical’s decades of amino acid manufacturing expertise, this content aligns with 2026 global regulatory standards to support informed decisions for pharma, nutraceutical and livestock production partners.


L-Methionine 2026 Guide: Pharmaceutical Grade Applications, Quality Standards & Reliable Sourcing

This comprehensive 2026 guide delivers actionable insights on L-Methionine for pharma procurement teams, formulators, and R&D professionals. It covers core biochemical properties, regulatory standards, real-world use cases, quality testing protocols, and practical sourcing tips, incorporating first-hand manufacturing experience and peer-reviewed research consensus to support informed decision-making.


L-Glutamic Acid: Pharmaceutical Grade Guide, Uses & Trusted Supplier 2026

This 2026 expert guide covers everything you need to know about L-Glutamic acid, from its definition and core applications to quality standards and best practices for sourcing bulk pharmaceutical grade material. Drawing on 18+ years of amino acid manufacturing experience at Jirong Pharmaceutical, we answer the most common questions to help you make informed purchasing decisions.


L-Glutamic Acid: Complete 2026 Guide to Pharmaceutical Grade Uses, Supply & Benefits

This expert-backed guide draws on Jirong Pharmaceutical’s 18+ years of amino acid manufacturing experience and 2026 industry data to break down everything you need to know about pharmaceutical grade L-Glutamic acid. We cover chemical properties, regulatory standards, common applications, storage best practices, and sourcing tips to answer all your frequently asked questions.


L-Glutamic Acid: Complete Guide to Pharmaceutical Grade Uses & Supply 2026

This 2026 updated guide covers all core information about L-Glutamic acid, from its chemical properties and common applications to quality grading and sourcing best practices. Drawing on decades of pharmaceutical amino acid manufacturing experience at Jirong Pharmaceutical, we answer top industry questions and deliver transparent, data-backed insights.


L-Glutamic Acid: Pharmaceutical Grade, Uses, Purity Standards & Supplier 2026

This 2026 comprehensive guide covers everything you need to know about L-Glutamic acid, including its chemical properties, purity grades, applications across pharma, food and biotech, and how to source high-quality bulk material. Drawing on Jirong Pharmaceutical’s 18+ years of amino acid manufacturing experience, we address common questions and share industry best practices.

Shijiazhuang Jirong Pharmaceutical Co., Ltd.

Address:  No.8 North of Huagong Road, Circular Chemical Industry Zone, Shijiazhuang, Hebei, China

Sales line:86-0311-85157950

All
  • All
  • Product Management

Power by:300.cn

Business license

SEO